Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 4-amino-2-(4-butanoylhexahydro-1h-1,4-diazepin-1-yl)-6,7-dimethoxyquinazoline Hcl
2. Andante
3. Bunazocine
4. Bunazosin
5. E 643
6. E-643
7. E643
1. 52712-76-2
2. Detantol
3. Bunazosin Hcl
4. E-643
5. 1-(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl)butan-1-one Hydrochloride
6. E643
7. Bunazosin Hydrochloride [jan]
8. 52712-76-2 (hcl)
9. 18v54tz7u6
10. E-1015
11. Ddq (pharmaceutical)
12. Bunazocine Hydrochloride
13. Andante
14. 1h-1,4-diazepine,1-(4-amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-4-(1-oxobutyl)-,monohydrochloride
15. Ncgc00183272-01
16. Unii-18v54tz7u6
17. Detantol (tn)
18. E 643
19. 4-amino-2-(4-butanoylhexahydro-1h-1,4-diazepin-1-yl)-6,7-dimethoxyquinazoline Hydrochloride
20. Dsstox_cid_28514
21. Dsstox_rid_82786
22. Dsstox_gsid_48588
23. 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1-oxobutyl)hexahydro-1h-1,4-diazepine Monohydrochloride
24. Schembl349737
25. Bunazosin Hydrochloride (jp17)
26. Chembl3182014
27. Dtxsid7048588
28. Chebi:31320
29. Bunazosin Hydrochloride [mi]
30. Tox21_112917
31. Akos016014364
32. Bunazosin Hydrochloride [mart.]
33. Bunazosin Hydrochloride [who-dd]
34. 1h-1,4-diazepine, Hexahydro-1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(1-oxobutyl)-, Monohydrochloride
35. Cas-52712-76-2
36. Ft-0659022
37. D01887
38. E 1015
39. A829218
40. Q27252034
41. 1-[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one;hydrochloride
42. 1-[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)-1,4-diazepan-1-yl]butan-1-one; Hydron; Chloride;bunazosin Hydrochloride
43. 1-butanone, 1-(4-(4-amino-6,7-dimethoxy-2-quinazolinyl)hexahydro-1h-1,4-diazepin-1-yl)-, Hydrochloride (1:1)
| Molecular Weight | 409.9 g/mol |
|---|---|
| Molecular Formula | C19H28ClN5O3 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 409.1880675 g/mol |
| Monoisotopic Mass | 409.1880675 g/mol |
| Topological Polar Surface Area | 93.8 Ų |
| Heavy Atom Count | 28 |
| Formal Charge | 0 |
| Complexity | 494 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Adrenergic alpha-1 Receptor Antagonists
Drugs that bind to and block the activation of ADRENERGIC ALPHA-1 RECEPTORS. (See all compounds classified as Adrenergic alpha-1 Receptor Antagonists.)
ABOUT THIS PAGE
A Bunazosin Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Bunazosin Hydrochloride, including repackagers and relabelers. The FDA regulates Bunazosin Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Bunazosin Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Bunazosin Hydrochloride supplier is an individual or a company that provides Bunazosin Hydrochloride active pharmaceutical ingredient (API) or Bunazosin Hydrochloride finished formulations upon request. The Bunazosin Hydrochloride suppliers may include Bunazosin Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Bunazosin Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Bunazosin Hydrochloride Drug Master File in Japan (Bunazosin Hydrochloride JDMF) empowers Bunazosin Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Bunazosin Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Bunazosin Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Bunazosin Hydrochloride suppliers with JDMF on PharmaCompass.
Bunazosin Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Bunazosin Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Bunazosin Hydrochloride GMP manufacturer or Bunazosin Hydrochloride GMP API supplier for your needs.
A Bunazosin Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Bunazosin Hydrochloride's compliance with Bunazosin Hydrochloride specifications and serves as a tool for batch-level quality control.
Bunazosin Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Bunazosin Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Bunazosin Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Bunazosin Hydrochloride EP), Bunazosin Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Bunazosin Hydrochloride USP).
LOOKING FOR A SUPPLIER?
